Denmark Totally Bans AstraZeneca COVID-19 Vaccine Amid Reports of Blood Clots

Denmark Totally Bans AstraZeneca COVID-19 Vaccine Amid Reports of Blood Clots
A vial of the AstraZeneca COVID-19 vaccine in Tirana, on March 13, 2021. (Gent Shkullaku/AFP via Getty Images)

Denmark became the first country in Europe to totally abandon the AstraZeneca COVID-19 vaccine, coming after the country and more than a dozen other European Union nations suspended its usage.

Denmark’s health agency director, Soren Brostrom, said Denmark will not use the shot as part of its vaccination campaign—despite the World Health Organization (WHO) and EU’s European Medicines Agency (EMA) saying that the benefits of using the AstraZeneca jab outweigh the negatives amid reports of rare blood clots.

“Overall, we must say that the results show that there is a real and serious side effect signal in the vaccine from AstraZeneca,” said Brostrom in a statement. “Based on an overall consideration, we have therefore chosen to continue the vaccination programme for all target groups without this vaccine.”

Noting that it is has been a “difficult decision” to make, Brostrom said the “upcoming target groups for vaccination are less likely to become severely ill from COVID-19,” and officials “must weigh this against the fact that we now have a known risk of severe adverse effects from vaccination with AstraZeneca, even if the risk in absolute terms is slight.”

Danish officials previously said that two people who had received the vaccine against the CCP (Chinese Communist Party) virus suffered from severe blood clots. One of them died, they said last month.

The CCP virus, also known as the novel coronavirus, is the virus that causes COVID-19.

In March, most of the countries that stopped using the AstraZeneca vaccine ultimately resumed using it.

On April 7, the EMA said that there is a “possible link” between rare blood clots and the vaccine, adding it “is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination.”

The statement continued: “So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”

The decision to not use AstraZeneca’s shot will push back the scheduled conclusion of Denmark’s vaccination scheme to early August from July 25, Danish officials said. Denmark also uses the U.S.-made Pfizer/BioNTech vaccine, which requires two shots.

Denmark was also the first nation to stop using the vaccine in March.

The Epoch Times has contacted AstraZeneca for comment.

AstraZeneca said in March that it “would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence,” adding that “a careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. ”

This week, U.S. health agencies recommended that the single-shot Johnson & Johnson vaccine be suspended amid reports of blood clots. The move was decried by former President Donald Trump, who, in a statement, said that he believes it was halted due to “possibly political reasons” as the Food and Drug Administration has more “love for Pfizer.”

Reuters contributed to this report.

From The Epoch Times